July 16, 2013

Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

July 16, 2013

The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”

July 15, 2013

The Food and Drug Administration has approved a generic opioid painkiller made by Actavis, the drug maker said.

July 15, 2013

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

July 15, 2013

The National Association of Specialty Pharmacy will begin developing pharmacy practice parameters in about 20 specialty therapeutic categories this year, the group said.

July 12, 2013

Actavis is looking to become the first to market a generic drug for epilepsy, the company said.

July 12, 2013

The Food and Drug Administration has approved a new lung cancer drug made by Boehringer Ingelheim, the agency said.

July 12, 2013

The National Community Pharmacists Association announced the introduction of a resource kit — Take Charge of Rx Benefits in Your Community — to help preempt anti-patient drug benefit designs, such as those that require the use of mail-order facilities for prescription drugs.

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

July 12, 2013

The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.

July 11, 2013

Legislation introduced in the Senate would coordinate efforts at various levels of government and industry to reduce the growing problem of prescription drug abuse.

July 11, 2013

The Food and Drug Administration has approved a Kremers Urban Pharmaceuticals drug for treating attention deficit hyperactivity disorder, the UCB subsidiary said.

July 11, 2013

Mylan is challenging a patent on a drug used to treat ulcerative proctitis, the generic drug maker said Thursday.

July 10, 2013

The National Community Pharmacists Association praised Hawaii elected officials for enacting two new laws that, respectively, will give the state’s residents greater choice of where to fill their prescriptions and additional medical privacy protections.

July 10, 2013

Patient care is local. And at the end of the day, when the book has been written on healthcare reform that simple fact will create more opportunity for community pharmacy owners — at least the ones who are able to seize that opportunity.

July 10, 2013

A new app for Android and the Apple iPhone aims to combine technology with psychology to reduce poor patient adherence to medication therapies.

July 10, 2013

Pharmacy ownership was once again a key aspect of McKesson ideaShare, as McKesson hosted its sixth annual RxOwnership program on June 29 to help advise independent pharmacy operators that are looking to buy or sell an existing store.

July 10, 2013

Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.

July 9, 2013

Amgen will get rights to a drug for cardiovascular disease approved in the European Union under a new deal with French drug maker Servier, the two companies said.

July 9, 2013

A nonprofit pharmacy advocacy group has launched a new project that it said was aimed at ensuring fair audit standards for prescription drug claims paid under the Medicare Part D program and protecting pharmacies and patients from what it called unfair audit and conduct practices by pharmacy benefit managers.

July 9, 2013

A total of 27 members of Congress issued a kind reminder to the Food and Drug Administration that many leaders across Capitol Hill are keeping tabs on New Dietary Ingredient guidance.

July 9, 2013

The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.

July 9, 2013

Mylan has received tentative approval for a generic version of a cholesterol drug made by AstraZeneca, according to Food and Drug Administration records.

July 9, 2013

The Food and Drug Administration has made a significant dent in its large backlog of generic drug applications thanks to amendments to last year's reauthorization of the Prescription Drug User Fee Act, the agency said.